Oropouche Virus: The Emerging Disease Spreading Across the Americas

If you've never heard of Oropouche virus, you're not alone — it's been quietly circulating in the Amazon basin since the 1950s, but it's only in the past couple of years that it's broken out of that range in a way that's put it on CDC's radar for mainstream Caribbean and South American travel destinations, not just remote rainforest itineraries.

It's often described as looking a lot like dengue, and it shares a lot of the same territory. But there are a few genuine differences worth knowing — including one that changes how you actually protect yourself.

What Oropouche is, and why it's spreading now

Oropouche virus was first identified in 1955 near the Oropouche River in Trinidad and Tobago, and for decades it stayed largely confined to the Amazon basin, cycling between forest mosquitoes/midges and wild animal hosts (sloths, primates, birds), with occasional human cases in people who'd spent time in those forested areas.

That changed starting in 2023–2024, when outbreaks began appearing in both traditional Amazon-basin areas and genuinely new regions — including Cuba, which confirmed its first-ever case in June 2024 and went on to report cases across the majority of its provinces. Since then, confirmed cases have been reported across a wide swath of the Americas, including Brazil (all 24 states at various points), Bolivia, Colombia, Peru, Ecuador, Guyana, Panama, the Dominican Republic, and Barbados, with travel-associated cases also turning up in the US and Europe among people returning from Cuba and Brazil specifically.

Because the outbreak situation shifts month to month, check the current picture before travel:

• CDC Oropouche Travel Health Notices
• PAHO Oropouche updates
• NaTHNaC TravelHealthPro

How it spreads — and why that matters for prevention

This is the detail that makes Oropouche genuinely different from dengue, chikungunya, and Zika: it's spread primarily by biting midges (tiny flies sometimes called "no-see-ums," specifically Culicoides paraensis), not mainly by mosquitoes. Some mosquito species (Culex quinquefasciatus, the same species involved in West Nile and St. Louis encephalitis transmission) can also spread it, but the midge is the dominant vector.

Why this matters practically: standard window and door screens often don't stop biting midges. Most household mesh has holes too large to exclude something midge-sized. If you're staying somewhere in an affected area, look specifically for fine 20x20 mesh screens, and don't assume a screened porch or "mosquito-proof" room is protecting you the way it would against dengue or malaria mosquitoes.

Symptoms: genuinely easy to mistake for dengue

Symptoms typically begin 3–10 days after a bite and include abrupt fever, severe headache, chills, muscle aches, joint pain, nausea, vomiting, and sensitivity to light — a symptom cluster that overlaps heavily with dengue, chikungunya, and Zika, all of which can circulate in the same regions at the same time. Most people recover within 3–6 days without long-term effects, but a notable feature of Oropouche is that up to 70% of people experience a recurrence of symptoms within days to weeks of apparently recovering — something not typical of the other arboviral look-alikes.

Rare but serious cases can progress to neuroinvasive disease, including meningitis, and Guillain-Barré syndrome has also been reported as a possible complication. There is currently no specific antiviral treatment — care is supportive, and if there's any chance your illness could be dengue instead (given the overlapping symptoms and regions), avoid aspirin and NSAIDs like ibuprofen because of dengue's bleeding risk, and use acetaminophen instead until dengue has been ruled out.

Pregnancy: a real and still-developing concern

Oropouche has been linked to serious adverse pregnancy outcomes, including fetal death, miscarriage, and congenital abnormalities, in a small but growing number of documented cases from Brazil and Cuba — this is a genuinely newer finding than the disease's decades-long history would suggest, since large-scale outbreaks with this kind of surveillance are recent. Health authorities in the UK and US have recommended that pregnant travellers reconsider non-essential travel to areas with a higher-level travel notice (currently assessed destination by destination, so check the live notice for your specific country), and if travel can't be avoided, strict bite prevention throughout the trip.

There's also emerging, though not yet confirmed, evidence around possible sexual transmission — replication-competent virus has been detected in semen in at least one documented case, though no actual case of sexual transmission has been confirmed to date. Out of caution, some health authorities suggest condom use or abstinence for several weeks after travel for couples concerned about this, similar in spirit to (though less firmly established than) the guidance for Zika.

Who's at higher risk of severe illness

Risk factors for more severe disease aren't fully defined yet, but likely mirror other mosquito/midge-borne viral infections: people aged 65 and older, and those with underlying conditions like hypertension, diabetes, cardiovascular disease, or immune suppression.

Prevention: the only real tool right now

With no vaccine and no treatment, prevention is everything:

• Use EPA-registered repellents specifically labelled effective against biting flies or Culicoides midges, not just generic mosquito repellent labelling — check the label rather than assuming.
• Look for genuinely fine mesh (20x20) on any screens, and consider a fan running in outdoor sitting areas, since midges are weak fliers and struggle against airflow.
• Continue bite prevention for 3 weeks after returning home, even if you feel fine — this reduces the (still theoretical for most regions, since midges aren't established outside the Americas) risk of contributing to onward spread if you were infected without realising it.
• If you develop symptoms within the first week of illness, keep up bite prevention specifically to avoid infecting local mosquitoes/midges who could then spread it further.

This is largely the same discipline covered in our mosquito bite prevention guide, with the added midge-specific mesh point layered on top.

How it compares to dengue

Given how often the two get confused, it's worth being direct: dengue remains the far larger and more established risk across the same countries, with millions of cases annually and a well-documented severe form (severe dengue) that Oropouche hasn't been shown to cause in comparable numbers. Oropouche is newer, less understood, and currently smaller in absolute case counts — but its recent expansion into new territory and the emerging pregnancy data are exactly why it's earned its own travel health notices rather than being folded into general "mosquito-borne illness" advice. See our dengue guide for the fuller picture on that comparison.

Getting the right advice

Check current country-specific notices using the Travel Vaccine Map tool before a Caribbean, Central American, or South American trip, and if you're pregnant or planning to be, talk to a travel health provider about your specific itinerary — use Find a Clinic to find one. Our pregnancy and children's travel vaccines guide covers how emerging risks like this fit into pregnancy travel planning more broadly.

Sources: CDC Oropouche, CDC Oropouche Prevention, PAHO Oropouche data and analysis, NaTHNaC TravelHealthPro – Oropouche.